
The acquisition brings Gallant’s experimental stem cell treatments for feline chronic gingivostomatitis and osteoarthritis in dogs and cats into Dechra’s portfolio.
Take a look at this week’s highlights.
As you shift gears and prepare for the weekend, we remain dedicated to delivering a robust mix of industry news right to your fingertips.
Here's a look at this week's highlights:
Keep up with our social media pages and on dvm360.com for more veterinary news coverage.




